Welcome to LookChem.com Sign In|Join Free
  • or
ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE is an organic compound that is part of the phenylpropanoic acids and derivatives class. It features an alpha, beta-unsaturated carboxylic ester structure with a bromo substituent at the beta-position, classifying it as a brominated ester. ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE also contains a bromine atom, indicating halogenation. Its molecular formula is C11H11BrO4, and it has a molar mass of 297.105 g/mol. Comprehensive information about its properties, reactivity, and safety can be found in various chemical databases and libraries.

133993-34-7

Post Buying Request

133993-34-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133993-34-7 Usage

Uses

ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE is used as a chemical intermediate in the synthesis of various organic compounds. Its unique structure, including the alpha, beta-unsaturated carboxylic ester skeleton and the bromo substituent, makes it a valuable building block for the development of new molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE is used as a key intermediate for the synthesis of pharmaceutical compounds. Its reactivity and structural features allow for the creation of new drug candidates with potential therapeutic applications.
Used in Chemical Research:
ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE is used as a research compound in academic and industrial laboratories. Its properties and reactivity are studied to understand its potential applications and to develop new synthetic methods for its preparation and modification.
Used in Material Science:
ETHYL 2-(2-BROMOACETYL)BENZENECARBOXYLATE is used as a component in the development of new materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of novel materials with improved characteristics for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 133993-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,9,9 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 133993-34:
(8*1)+(7*3)+(6*3)+(5*9)+(4*9)+(3*3)+(2*3)+(1*4)=147
147 % 10 = 7
So 133993-34-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H11BrO3/c1-2-15-11(14)9-6-4-3-5-8(9)10(13)7-12/h3-6H,2,7H2,1H3

133993-34-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(2-bromoacetyl)benzoate

1.2 Other means of identification

Product number -
Other names ethylbromoacetylbenzenecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133993-34-7 SDS

133993-34-7Relevant academic research and scientific papers

NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS

-

Paragraph 0298, (2019/01/21)

The present invention discloses compounds according to Formula (I) Wherein R1, R2, L, A1, A2, A3, Cy and the subscript n are as defined herein. The present invention relates to antagonists compounds of sphingosine 1-phosphate (SIP) receptor, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, inflammatory diseases, respiratory diseases, autoimmune diseases, metabolic diseases, cardiovascular diseases, and/or proliferative diseases by administering the compound of the invention.

Synthesis of dibenzocycloketones by acyl radical cyclization from aromatic carboxylic acids using methylene blue as a photocatalyst

Jiang, Hongshuo,Mao, Guijie,Wu, Hongfeng,An, Qi,Zuo, Minghui,Guo, Weihao,Xu, Chunzhao,Sun, Zhizhong,Chu, Wenyi

supporting information, p. 5368 - 5373 (2019/10/11)

An efficient intramolecular radical cyclization reaction via photoredox catalysis was developed for the synthesis of dibenzocycloketone derivatives using methylene blue as a photosensitizer. This strategy could be widely used to synthesize large heterocycles due to the unique reactivity of phosphoranyl radicals formed by a polar/SET crossover between an aromatic carboxylic acid and a phosphine radical cation. Attractive features of this process include generation of an acyl radical by an inexpensive and metal-free photocatalyst, which effectively undergoes a cyclization process.

Synthesis of New Benzofuro and Indolobenzoazepin-6-ones

Viti, Giovanni,Giannotti, Danilo,Nannicini, Rossano,Ricci, Renzo,Pestellini, Vittorio

, p. 379 - 384 (2007/10/02)

Three new tetracyclic structures, containing the azepine ring, were synthesized: 11,12-dihydro-6H-benzofurobenzoazepine-6,11-dione, 5,6,11,12-tetrahydroindolobenzoazepine-6,11-dione and 11,12-dihydro-6H-benzofurobenzoazepin-6

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 133993-34-7